Skip to main content
logo
Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
0.9000
+0.0299 (3.44%)
At close: Nov 3, 2026, 4:00 PM EST
0.9130
+0.0130 (1.44%)
After-hours: Nov 3, 2026, 5:45 PM EST

Imunon Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----0.50.5
Revenue Growth
----0%0%
Cost of Revenue
0.41----10.62
Gross Profit
-0.41---0.5-10.12
Selling, General & Admin
6.656.877.499.7413.6910.89
Research & Development
7.787.7811.6411.2911.73-
Operating Expenses
14.4314.6519.1321.0325.4210.89
Operating Income
-14.84-14.65-19.13-21.03-24.92-21.01
Interest Expense
-0.08---0.2-5.03-0.57
Interest & Investment Income
0.180.160.511.160.450.01
Other Non Operating Income (Expenses)
0.02---0.400
EBT Excluding Unusual Items
-14.72-14.5-18.62-20.47-29.5-21.56
Impairment of Goodwill
------1.98
Other Unusual Items
----0.335.41.39
Pretax Income
-14.72-14.5-18.62-20.8-37.47-22.15
Income Tax Expense
----1.28-1.57-1.38
Net Income
-14.72-14.5-18.62-19.51-35.9-20.77
Preferred Dividends & Other Adjustments
0.02-----
Net Income to Common
-14.73-14.5-18.62-19.51-35.9-20.77
Net Income Growth
------
Shares Outstanding (Basic)
421110
Shares Outstanding (Diluted)
421110
Shares Change
217.32%93.23%58.46%26.63%31.62%154.70%
EPS (Basic)
-3.57-6.83-16.94-28.14-65.55-49.92
EPS (Diluted)
-3.57-6.83-16.94-28.14-65.55-49.92
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-15.18-14.18-18.88-19.47-23.36-16.54
Free Cash Flow Per Share
-3.68-6.68-17.18-28.08-42.66-39.74
Gross Margin
----100.00%-
Operating Margin
-----4984.31%-4201.44%
Profit Margin
-----7179.65%-4153.85%
Free Cash Flow Margin
-----4672.94%-3307.04%
EBITDA
-14.55-14.36-18.89-20.78-24.73-20.3
D&A For EBITDA
0.290.290.240.250.20.7
EBIT
-14.84-14.65-19.13-21.03-24.92-21.01
SEC Filings: 10-K · 10-Q